201. In Vitro Activity and β-Lactamase Stability of Cefazaflur Compared with Those of β-Lactamase-Stable Cephalosporins
- Author
-
Nalinee Aswapokee and Harold C. Neu
- Subjects
medicine.drug_class ,Klebsiella pneumoniae ,Penicillin Resistance ,Cephalosporin ,Penicillins ,Serratia ,beta-Lactamases ,Microbiology ,Drug Stability ,Physiological Effects and Microbial Susceptibility ,polycyclic compounds ,medicine ,Pharmacology (medical) ,Cefoxitin ,Cefamandole ,Cephalosporinase ,Pharmacology ,Bacteria ,biology ,Chemistry ,Enterobacter ,biochemical phenomena, metabolism, and nutrition ,bacterial infections and mycoses ,biology.organism_classification ,Proteus mirabilis ,Cephalosporins ,Proteus ,Infectious Diseases ,bacteria ,medicine.drug - Abstract
The in vitro activity of cefazaflur, a parenteral cephalosporin, was determined against 590 clinical isolates. Cefazaflur inhibited the majority of gram-positive cocci at concentrations below 1 μg/ml except for enterococci. The agent was as active as cefamandole or cefoxitin against most Escherichia coli, Klebsiella pneumoniae , and Proteus mirabilis . Although it inhibited a number of strains of Enterobacter , indole-positive Proteus , and Serratia resistant to cephalothin, it was much less active against these organisms than were cefamandole or cefoxitin.
- Published
- 1979
- Full Text
- View/download PDF